ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/28 | 1,660 | 1,686 | 1,655 | 1,665 | +15 | +0.9% | 281,400 |
2018/09/27 | 1,685 | 1,715 | 1,642 | 1,650 | -30 | -1.8% | 649,200 |
2018/09/26 | 1,607 | 1,697 | 1,605 | 1,680 | +80 | +5% | 1,114,600 |
2018/09/25 | 1,618 | 1,618 | 1,593 | 1,600 | +3 | +0.2% | 255,600 |
2018/09/21 | 1,567 | 1,600 | 1,561 | 1,597 | +30 | +1.9% | 377,100 |
2018/09/20 | 1,586 | 1,634 | 1,552 | 1,567 | +17 | +1.1% | 1,007,500 |
2018/09/19 | 1,550 | 1,604 | 1,542 | 1,550 | -21 | -1.3% | 466,800 |
2018/09/18 | 1,530 | 1,593 | 1,530 | 1,571 | +26 | +1.7% | 387,000 |
2018/09/14 | 1,514 | 1,545 | 1,502 | 1,545 | +40 | +2.7% | 264,200 |
2018/09/13 | 1,477 | 1,518 | 1,472 | 1,505 | +14 | +0.9% | 326,800 |
2018/09/12 | 1,516 | 1,550 | 1,486 | 1,491 | -48 | -3.1% | 423,600 |
2018/09/11 | 1,568 | 1,590 | 1,538 | 1,539 | -28 | -1.8% | 244,600 |
2018/09/10 | 1,537 | 1,574 | 1,527 | 1,567 | +9 | +0.6% | 273,700 |
2018/09/07 | 1,515 | 1,558 | 1,475 | 1,558 | +23 | +1.5% | 471,800 |
2018/09/06 | 1,591 | 1,597 | 1,516 | 1,535 | -69 | -4.3% | 790,400 |
2018/09/05 | 1,609 | 1,626 | 1,594 | 1,604 | -2 | -0.1% | 400,600 |
2018/09/04 | 1,592 | 1,624 | 1,571 | 1,606 | +8 | +0.5% | 578,900 |
2018/09/03 | 1,609 | 1,654 | 1,584 | 1,598 | +28 | +1.8% | 700,200 |
2018/08/31 | 1,554 | 1,574 | 1,531 | 1,570 | -1 | -0.1% | 477,800 |
2018/08/30 | 1,589 | 1,601 | 1,553 | 1,571 | +12 | +0.8% | 550,300 |
2018/08/29 | 1,550 | 1,576 | 1,529 | 1,559 | +28 | +1.8% | 618,200 |
2018/08/28 | 1,542 | 1,568 | 1,477 | 1,531 | +12 | +0.8% | 774,300 |
2018/08/27 | 1,470 | 1,544 | 1,464 | 1,519 | +66 | +4.5% | 941,400 |
2018/08/24 | 1,438 | 1,473 | 1,435 | 1,453 | +18 | +1.3% | 418,100 |
2018/08/23 | 1,438 | 1,465 | 1,410 | 1,435 | +27 | +1.9% | 653,800 |
2018/08/22 | 1,337 | 1,421 | 1,337 | 1,408 | +60 | +4.5% | 656,500 |
2018/08/21 | 1,341 | 1,380 | 1,323 | 1,348 | -17 | -1.2% | 416,300 |
2018/08/20 | 1,390 | 1,437 | 1,365 | 1,365 | -34 | -2.4% | 489,800 |
2018/08/17 | 1,333 | 1,431 | 1,329 | 1,399 | +84 | +6.4% | 949,900 |
2018/08/16 | 1,342 | 1,342 | 1,276 | 1,315 | -34 | -2.5% | 566,800 |
2018/08/15 | 1,390 | 1,395 | 1,330 | 1,349 | -11 | -0.8% | 565,600 |
2018/08/14 | 1,272 | 1,372 | 1,272 | 1,360 | +88 | +6.9% | 762,200 |
2018/08/13 | 1,250 | 1,322 | 1,247 | 1,272 | +3 | +0.2% | 739,300 |
2018/08/10 | 1,259 | 1,283 | 1,241 | 1,269 | ±0 | ±0% | 464,300 |
2018/08/09 | 1,284 | 1,310 | 1,247 | 1,269 | -15 | -1.2% | 492,300 |
2018/08/08 | 1,264 | 1,294 | 1,237 | 1,284 | +20 | +1.6% | 497,400 |
2018/08/07 | 1,276 | 1,316 | 1,262 | 1,264 | -15 | -1.2% | 351,900 |
2018/08/06 | 1,234 | 1,286 | 1,205 | 1,279 | +30 | +2.4% | 714,500 |
2018/08/03 | 1,300 | 1,319 | 1,241 | 1,249 | -44 | -3.4% | 558,600 |
2018/08/02 | 1,300 | 1,325 | 1,293 | 1,293 | -26 | -2% | 508,600 |
2018/08/01 | 1,302 | 1,328 | 1,289 | 1,319 | +27 | +2.1% | 514,400 |
2018/07/31 | 1,297 | 1,326 | 1,264 | 1,292 | +11 | +0.9% | 1,140,100 |
2018/07/30 | 1,380 | 1,382 | 1,277 | 1,281 | -127 | -9% | 1,626,000 |
2018/07/27 | 1,426 | 1,451 | 1,402 | 1,408 | -25 | -1.7% | 802,700 |
2018/07/26 | 1,436 | 1,446 | 1,398 | 1,433 | -20 | -1.4% | 910,200 |
2018/07/25 | 1,478 | 1,478 | 1,435 | 1,453 | -26 | -1.8% | 737,200 |
2018/07/24 | 1,442 | 1,479 | 1,416 | 1,479 | +14 | +1% | 996,700 |
2018/07/23 | 1,530 | 1,538 | 1,465 | 1,465 | -87 | -5.6% | 1,183,800 |
2018/07/20 | 1,611 | 1,635 | 1,531 | 1,552 | +129 | +9.1% | 4,466,200 |
2018/07/19 | 1,471 | 1,485 | 1,418 | 1,423 | -43 | -2.9% | 792,400 |
1501~
1550
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム